Novoron Bioscience
UEI: K4L2JH8P6EE5
• CAGE: 6VEW2
Overview
Awardee Type
Parent
Company Description
Novoron Bioscience develops new therapeutic approaches to address
neurological damage or disease in the central nervous system (CNS).
Name
Novoron Bioscience
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
Sept. 16, 2025
Calculating
Novoron Bioscience is a federal grant recipient (UEI K4L2JH8P6EE5; CAGE 6VEW2). It is headquartered in San Diego, CA. Its primary registered NAICS is 541714: Research and Development in Biotechnology (except Nanobiotechnology). The corporation was founded in January 2014 and federally registered in June 2026.
Federal Award Analysis
Novoron Bioscience federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NOVORON BIOSCIENCE INC
UEI
K4L2JH8P6EE5
CAGE Code
6VEW2
SBA Certifications
None
Self Certifications
Minority Owned Business
Native American Owned
Native American Owned
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 10, 2014
Initial Registration
June 30, 2026
Last Registration
July 1, 2026
Registration Activation
July 1, 2026
Registration Expiration
June 30, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No